We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
126 hedge funds and large institutions have $309M invested in Puma Biotechnology in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 42 increasing their positions, 43 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
12.75% more ownership
Funds ownership: 80.46% → 93.21% (+13%)
13% more capital invested
Capital invested by funds: $274M → $309M (+$34.7M)
2% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 43
9% less call options, than puts
Call options by funds: $3.45M | Put options by funds: $3.81M
5% less funds holding
Funds holding: 133 → 126 (-7)
21% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 24
Holders
126
Holders Change
-7
Holders Change %
-5.26%
% of All Funds
2.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
42
Reduced
43
Closed
24
Calls
$3.45M
Puts
$3.81M
Net Calls
-$354K
Net Calls Change
-$978K
Top Buyers
Top Sellers
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
-$7.78M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.6M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$2.9M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.49M |
| 5 |
WG
Winton Group
London,
United Kingdom
|
-$2.05M |
